Repligen | RGEN - 流动负债

金融业

USD

USD 2.93B

现金及等价物

USD 582.65M

USD 85.97M

USD 1.16B

USD 126.21M

USD 546.59M

USD 19.98M

USD 40.01M

1.78K

EPS每股收益

USD 0.48

股本和储备

USD 2.11B

USD 108.28M

债务利息支出

USD 5.58M

USD 7.31M

USD 546.59M

USD 7.26B

USD 8.33M

USD 174.27M

USD 19.98M

普通股股本

USD 56.4M

109.48

USD 19.11M

USD 194M

销售和管理费用

USD 76.54M

USD 179.26M

贸易债权人

USD 34.66M

应收帐款人

USD 151.55M

	流动负债	更改		日
Agilent	USD 2.27B		35M	2026-03
Align Technology	USD 1.91B		14.16M	2026-03
Bio Techne	USD 153.28M		12.85M	2026-03
BioMarin Pharmaceutical	USD 793.15M		34.12M	2026-03
Bristol-Myers Squibb	USD 19.16B		4.26B	2026-03
Bruker	USD 1.36B		75.9M	2026-03
Charles River Laboratories	USD 1.09B		26.61M	2026-03
Danaher	USD 7.46B		653M	2026-03
Dentsply International	USD 1.21B		136M	2026-03
General Electric Aerospace	USD 40.03B		1.05B	2026-03
Henry Schein	USD 3.3B		69M	2026-03
Illumina	USD 1.57B		19M	2026-03
IQVIA Holdings	USD 8.33B		9M	2026-03
Mettler Toledo International	USD 1.11B		89.76M	2026-03
Myriad Genetics	USD 130.2M		3.6M	2026-03
OraSure Technologies	USD 44.08M		4.29M	2026-03
Pacific Biosciences Of California	USD 65.36M		7.48M	2026-03
Pfizer	USD 34.35B		2.64B	2026-03
Repligen	USD 126.21M		9.62M	2026-03
Revvity	USD 1.24B		92.6M	2026-03
Standard Biotools	USD 42.2M		66.1M	2026-03
Thermo Fisher Scientific	USD 14.62B		568M	2026-03
Waters	USD 1.24B		11.8M	2025-12
West Pharmaceutical Services	USD 674M		19.1M	2026-03